Vito Maurizio Parato

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

The left atrial appendage: from embryology to prevention of thromboembolism

Giuseppe Patti, Vittorio Pengo, Rossella Marcucci et al. · European Heart Journal · 2016 · 78 citations · Full text

Medicine, Cardiology, Surgery +17

Resting Echocardiography for the Early Detection of Acute Coronary Syndromes in Chest Pain Unit Patients

Vito Maurizio Parato, Anjlee Mehta, Domenico Vittorio Delfino et al. · Echocardiography · 2010 · 25 citations

Medicine, Cardiology, Internal Medicine +17

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i> -Related Dilated Cardiomyopathy

Pablo García‐Pavía, José F. Rodríguez‐Palomares, Gianfranco Sinagra et al. · Circulation Heart Failure · 2024 · 23 citations · Full text

Medicine, Cardiology, Internal Medicine +5

Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

Leonardo De Luca, Pier Luigi Temporelli, Carmine Riccio et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2019 · 17 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10